Thiol Disulfide Balance and Oxidative Stress Change in Endometrial Polyp Patients
NCT ID: NCT06826495
Last Updated: 2025-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
54 participants
OBSERVATIONAL
2021-01-02
2022-01-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oxidative Stress in Polycystic Ovary Syndrome
NCT06826625
The Effect of Polycystic Ovary Syndrome on Pelvic Floor Structure and Function
NCT04398186
Evaluation of Serum Scube-1 Scube-2 and Scube-3 Levels in Patients With Polikistik Over Syndrome ,
NCT03765905
Congenital Uterine Anomalies & Pregnancy in Polycystic Ovarian Syndrome
NCT04776915
Ocular Findings of Polycystic Ovary Syndrome
NCT03896841
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
endometrial polyps
Women with endometrial polyp
No interventions assigned to this group
control group
Participants in the control group were confirmed to be free of endometrial polyps via TVUSG and saline infusion ultrasonography
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
• To be without endometrial polyp
For the polyp group, they were as follows:
* Individuals experiencing menometrorrhagia
* A body mass index (BMI) of 25 or more
* Hypertension
* Endometrial polyps detected via saline infusion ultrasonography
Exclusion Criteria
* Diabetes mellitus
* Pelvic mass
* Malignancy
* The use of Tamoxifen, hormonal contraceptives, or hormone replacement therapy.
20 Years
48 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mardin Artuklu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hasan Basri Savas
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alanya Training and Research Hospital Gynecology and Obstetrics Department
Antalya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10354421-2020/23-8
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.